New High-Impact Research in Infectious Diseases
Hannah Calkins Jan 06, 2023
The faculty of the Division of Infectious Diseases in the Department of Medicine at IU School of Medicine continue to demonstrate their scholarly productivity with high-level publications relevant to the global healthcare community.
Recently, two faculty leaders published manuscripts addressing significant and timely topics in Lancet subspecialty journals.
“Infections caused by Clostridium perfringens and Paeniclostridium sordellii after unsafe abortion”
Lancet Infectious Diseases, 2022
David Aronoff, MD
(Read the Paper)
Dr. Aronoff’s recent article in Lancet Infectious Diseases provides a holistic clinical review for all medical providers of these two feared infectious complications of unsafe abortion practices. Dr. Aronoff is chair of the Department of Medicine, a member of the Division of Infectious Diseases, and an internationally known expert in anaerobic and reproductive health infections.
“Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial”
Lancet HIV, 2023
Samir Gupta, MD
(Read the Paper)
Dr. Gupta served as the lead academic investigator in a phase 2 multicenter trial studying the use of the newly developed, long-acting HIV medication lenacapavir, which can be administer subcutaneously every 6 months, as part of initial treatment combinations for people with HIV. This trial’s results, now published in Lancet HIV, support ongoing studies with this new agent for both treatment and prevention of HIV. Dr. Gupta is Director of the Division of Infectious Diseases and of the ID Clinical Trials Unit.